Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint […]
The pathogen Clostridium difficile, which causes one of the most common hospital-acquired infections in the United States, may have accomplices that until now have gone largely unnoticed. This week in mSphere, researchers report finding fungi […]
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, announced completion of construction of a new state-of-the-art manufacturing facility. The new facility is located at the company’s headquarters in Ness Ziona and […]
How many stars are there in the observable universe? It was once deemed an impossible question, but astronomers have gleaned an answer–about one billion trillion of them. Now, scientists at Harvard Medical School and Joslin […]
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna International Group (SIG), Symbiosis LLC and […]
The National Microbiome Data Collaborative (NMDC), a new initiative aimed at empowering microbiome research, is gearing up its pilot phase after receiving $10 million from the U.S. Department of Energy (DOE) Office of Science. Spearheaded […]
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response, a […]
Webinar Presentation by Alex Buko, Vice President Business and Product Development at Human Metabolome Technologies America.
UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice. The study published this week by the Journal of Experimental Medicine could lay the […]
LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women’s health. Ravel will serve as LUCA’s Chief Scientist. The company’s first […]
A new study published in the peer-reviewed journal Hepatology Communications finds that the multi-strain De Simone Formulation probiotic medical food may help in the dietary management of dysbiosis associated with cirrhosis by improving cognitive function, […]